Pfizer Loses Lyrica Patent Battle in UK Supreme Court

Pfizer’s appeal for a second patent on Lyrica (pregabalin) has been denied by the UK’s highest court, ending the pharma giant’s long-running fight against drug companies marketing generic versions of its blockbuster pain treatment.
Source: International Pharmaceutical Regulatory Monitor